MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT

FDA Drug Profile — STOPAIN CLINICAL Migraine and Headache

MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including STOPAIN CLINICAL Migraine and Headache. Available dosage form: gel.

Drug details

Generic Name
MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT
Brand Names
STOPAIN CLINICAL Migraine and Headache
Sponsor
Troy Manufacturing, Inc.
NDC Codes
1
Dosage Forms
GEL
Routes
TOPICAL
Active Ingredients
MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT

Indications and Usage

Uses Temporarily relieves head pain associated with migraine and headache.

Warnings

Warnings For external use only. This product should not be used topically on children younger than 2 years of age nor should it be applied on any mucus membranes of any age child or adult. Seek the advice of your healthcare professional before using this product topically on children 2-12 years of age. Avoid contact with eyes. If gel gets in eyes or on muscus membranes flush with cool water for 1-2 minutes Ask a doctor before use if you have never had migraines diagnosed by a health professional • Do not apply to broken or irritated skin • Do not apply to forehead or temples Keep out of reach of children. If swallowed, get medicial help or contact a Poison Control Center. Stop use and consult a doctor if • condition worsens or symptoms persist for more than 7 days or clear up and occur again within a few days • redness is present • excessive irritation of the skin occurs If pregnant or breast feeding ask a health professional before use.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.